Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
| ▸ | POLB | P06746 | 4/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | CASP3 | P42574 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.50 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.50 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.50 |
| ▸ | NPBWR1 | P48145 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | NOS1 | P29475 | 1/20 | 0.49 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30642229 | 0.87 | ALDH1A1 (1.00) | ALDH1A1TDP1MAPTPOLBNPC1 | |
| SCHEMBL833509 | 0.87 | ALDH1A1 (1.00) | ALDH1A1TDP1MAPTPOLBNPC1 | |
| SCHEMBL27567547 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TDP1MAPTPOLBNPC1 | |
| SCHEMBL16066049 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TDP1MAPTPOLBNPC1 | |
| SCHEMBL4328210 | 0.81 | ALDH1A1 (0.58) | ALDH1A1TDP1MAPTPOLBNPC1 | |
| SCHEMBL2711226 | 0.81 | ALDH1A1 (0.58) | ALDH1A1TDP1MAPTPOLBNPC1 | |
| SCHEMBL18758065 | 0.81 | ALDH1A1 (0.58) | ALDH1A1TDP1MAPTPOLBNPC1 | |
| SCHEMBL1541188 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TDP1MAPTPOLBNPC1 | |
| SCHEMBL8260455 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TDP1MAPTPOLBNPC1 | |
| SCHEMBL31536798 | 0.80 | ALDH1A1 (0.56) | ALDH1A1TDP1MAPTPOLBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120082889-A | Alkaline microetching solution and preparation method and microetching method thereof | 深圳市板明科技股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-119606958-A | Composition containing pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| US-10292390-B2 | Inhibition and dispersion of bacterial biofilms with 2-aminobenzimidazole derivatives | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-05-21 | — | — | US | claimed |
| CN-105384693-B | Compound, its synthetic method and the purposes of the structure of bisazo containing benzoxazole ring | 盐城工学院 | 2018-11-09 | — | — | CN | claimed |
| CN-105384693-A | Compound containing benzoxazole ring bis(azo) structure, synthetic method for compound and use of compound | YANCHENG INST TECHNOLOGY | 2016-03-09 | — | — | CN | claimed |
| EP-2724156-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASE | The Jackson Laboratory (US) | 2014-04-30 | — | — | EP | claimed |
| CN-103765212-A | Methods and compositions for treating cancer and autoimmune diseases | JACKSON LAB | 2014-04-30 | — | — | CN | claimed |
| US-20130136782-A1 | Inhibition and Dispersion of Bacterial Biofilms with 2-Aminobenzimidazole Derivatives | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2013-05-30 | — | — | US | claimed |
| WO-2013003112-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASE | THE JACKSON LABORATORY (US) | 2013-01-03 | — | — | WO | claimed |
| CN-120082889-A | Alkaline microetching solution and preparation method and microetching method thereof | 深圳市板明科技股份有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-119606958-B | Composition containing pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-117126578-B | Organosilicon polymer/POSS hybrid antifouling coating grafted with antibacterial molecules and preparation method thereof | 中国科学院海洋研究所 | 2025-04-22 | — | — | CN | disclosed |
| CN-119606958-A | Composition containing pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-117126578-A | Organosilicon polymer/POSS hybrid antifouling coating grafted with antibacterial molecules and preparation method thereof | 中国科学院海洋研究所 | 2023-11-28 | — | — | CN | disclosed |
| WO-2006099379-A2 | BENZAZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE AS B-SECRETASE INHIBITORS | TRANSTECH PHARMA, INC. (US) | 2006-09-21 | — | — | WO | disclosed |
| EP-1674466-A1 | 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors | 4SC AG (DE) | 2006-06-28 | — | — | EP | disclosed |
| WO-2004092181-A9 | HETEROCYCLIC MCHR1 ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2005-01-27 | — | — | WO | disclosed |
| EP-0023889-B1 | IMINOISOINDOLINONE METAL COMPLEXES, PROCESS FOR THEIR MANUFACTURE, METHOD FOR PIGMENTING AN ORGANIC HIGH-MOLECULAR MATERIAL AND HIGH-MOLECULAR ORGANIC MATERIAL CONTAINING SUCH A METAL COMPLEX | CIBA-GEIGY AG (CH) | 1983-03-09 | — | — | EP | disclosed |
| EP-0023889-A1 | Iminoisoindolinone metal complexes, process for their manufacture, method for pigmenting an organic high-molecular material and high-molecular organic material containing such a metal complex | CIBA-GEIGY AG (CH) | 1981-02-11 | — | — | EP | disclosed |
| US-4065462-A | ORGANIC PIGMENTS | CIBA-GEIGY CORPORATION (US) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130136782-A1 | Inhibition and Dispersion of Bacterial Biofilms with 2-Aminobenzimidazole Derivatives | FLNB, BRI3BP, CCNI | ALDH1A1 1841/4885TDP1 3754/4885MAPT 3578/4885 |
| US-10292390-B2 | Inhibition and dispersion of bacterial biofilms with 2-aminobenzimidazole derivatives | FLNB, BRI3BP, CCNI | ALDH1A1 1841/4885TDP1 3754/4885MAPT 3578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.